Profile
Mr. Romeo Mirzac is Chief Accounting Officer at Proteostasis Therapeutics, Inc.
He received his undergraduate degree from the Bucharest Academy of Economic Studies and a graduate degree from the University of New Hampshire.
Former positions of Romeo Mirzac
| Companies | Position | End |
|---|---|---|
| PROTEOSTASIS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2016-03-17 |
Training of Romeo Mirzac
| University of New Hampshire | Graduate Degree |
| Bucharest Academy of Economic Studies | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Romeo Mirzac
